A recent study supported this idea through the study of non-coding nuclear-enriched abundant transcript 2 (NEAT2), commonly known as Malat1. Previous studies have shown that Malat1, expressed in high levels, correlates with poor prognosis in various cancers, including liver cancer [26]. This evidence concerns the gene MALAT1 and cancer.